New cancer clinical trial: An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
Published on: August 03, 2017 at 12:00PM
Conditions: Triple Negative Breast Cancer; Metastatic Breast Cancer
Interventions: Drug: Gedatolisib; Drug: PTK7-ADC
Sponsor: Kathy Miller
Not yet recruiting – verified July 2017
http://ift.tt/2hJkNtN
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM